AlphaFold predicted structure
NAGA · P17050

Mean pLDDT
96.1/ 100
Very high
411 residues
Confidence breakdown
- Very high(≥ 90)94%
- Confident(70–90)2%
- Low(50–70)1%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
alpha-N-acetylgalactosaminidase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalLysosomal storage disorder
BIALLELIC, autosomal or pseudoautosomal+4 more panels — install the extension to see the full list inline on any page.
alpha-N-acetylgalactosaminidase deficiency type 2
alpha-N-acetylgalactosaminidase deficiency
alpha-N-acetylgalactosaminidase deficiency type 1
alpha-N-acetylgalactosaminidase deficiency type 3
hereditary disease
Seizure
neurodegenerative disease
Intellectual disability
intelligence
arthrogryposis multiplex congenita
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Alpha-N-acetylgalactosaminidase
Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids
NAGA · P17050

Mean pLDDT
96.1/ 100
Very high
411 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0